Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-047755

CEO sold 11,091 shares at $13.05 ($144,782)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-21 Sale : show line 1 in the form −11,091 $13.05 $144,782 707,328 D
Open-market sales · 11,091 sh · avg $13.05 · $144,782
Loading xslF345X05/form4.xml…